SCHEMBL30869153

SCHEMBL30869153

COC(=O)CCc1cc(NC(=O)COCCCCNC(=O)OC(C)(C)C)c2cnn(C3CCCCO3)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATR Q13535 3/20 0.41
▸ RXRA P19793 1/20 0.34
▸ RXRB P28702 1/20 0.34
▸ RXRG P48443 1/20 0.34
▸ FPR3 P25089 2/20 0.33
▸ FPR2 P25090 2/20 0.33
▸ TP53 P04637 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ CYP3A4 P08684 1/20 0.32
▸ NAMPT P43490 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ KRAS P01116 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ DDB1 Q16531 1/20 0.32
▸ CRBN Q96SW2 1/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30869139 0.90 ATR (0.42) ATRRXRARXRBRXRGFPR3
SCHEMBL30797740 0.87 ATR (0.43) ATRRXRARXRBRXRGFPR3
SCHEMBL30797676 0.84 ATR (0.42) ATRRXRARXRBRXRGFPR3
SCHEMBL30797774 0.81 ATR (0.40) ATRFPR3FPR2TP53TSHR
SCHEMBL30869070 0.77 ATR (0.42) ATRRXRARXRBRXRGFPR3
SCHEMBL30869074 0.76 ATR (0.43) ATRRXRARXRBRXRGFPR3
SCHEMBL30797730 0.76 ATR (0.44) ATRRXRARXRBRXRGFPR3
SCHEMBL30869126 0.75 ATR (0.40) ATRRXRARXRBRXRGFPR3
SCHEMBL30869008 0.75 ATR (0.39) ATRRXRARXRBRXRGFPR3
SCHEMBL30869078 0.75 ATR (0.45) ATRFPR3FPR2DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584249-A1 NOVEL COMPOUNDS AS CK2 INHIBITORS Cambridge Enterprise Limited (GB) 2025-07-16 — — EP disclosed
WO-2024052702-A1 NOVEL COMPOUNDS AS CK2 INHIBITORS CAMBRIDGE ENTERPRISE LIMITED (GB) 2024-03-14 — — WO disclosed
Send feedback